The association between Interleukins 6, 8, and 10 levels and response to treatment of the hepatitis C virus with direct-acting antiviral.

Association of Serum Interlukin-6 and Transforming Growth Factor Beta with Response to Antiviral Therapy for Chronic Hepatitis C Patients

ROLE OF SERUM INTERLEUKIN – 10 AND INTERLEUKIN -28B GENE POLYMORPHISMS IN PREDICTING TREATMENT RESPONSE OF HEPATITIS C PATIENTS

Study of Interleukin-18 in Chronic hepatitis C virus related liver diseases

A PREDICTIVE AND COMPARATIVE STUDY VIA VIRAL AND BIOCHEMICAL MEASUREMENTS FOR RESPONDERS AND NON-RESPONDERS EGYPTIAN HEPATITIS C PATIENTS TO DACLATASVIR PLUS SOFOSBUVIR THERAPY

Comparative Study between Responders and Non Responders Among Patients Treated for Hepatitis C virus Infection

Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Interleukin 17 levels used as diagnostic marker for following up hepatitis C virus treatment

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients